General Information of Drug Off-Target (DOT) (ID: OTVOJJLJ)

DOT Name Megakaryocyte-associated tyrosine-protein kinase (MATK)
Synonyms EC 2.7.10.2; CSK homologous kinase; CHK; Hematopoietic consensus tyrosine-lacking kinase; Protein kinase HYL; Tyrosine-protein kinase CTK
Gene Name MATK
Related Disease
Neuroblastoma ( )
Acute monocytic leukemia ( )
Acute myelogenous leukaemia ( )
Adenovirus infection ( )
Adult glioblastoma ( )
Astrocytoma ( )
Brain neoplasm ( )
Breast cancer ( )
Breast carcinoma ( )
Breast neoplasm ( )
Colonic neoplasm ( )
Dengue ( )
Glioblastoma multiforme ( )
Hepatitis C virus infection ( )
leukaemia ( )
Leukemia ( )
Lung cancer ( )
Lung carcinoma ( )
Multiple sclerosis ( )
Pancreatic cancer ( )
T-cell acute lymphoblastic leukaemia ( )
T-cell lymphoma ( )
Visceral leishmaniasis ( )
Advanced cancer ( )
Hemolytic-uremic syndrome ( )
UniProt ID
MATK_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1JWO; 1X6G; 3US4
EC Number
2.7.10.2
Pfam ID
PF07714 ; PF00017 ; PF00018
Sequence
MAGRGSLVSWRAFHGCDSAEELPRVSPRFLRAWHPPPVSARMPTRRWAPGTQCITKCEHT
RPKPGELAFRKGDVVTILEACENKSWYRVKHHTSGQEGLLAAGALREREALSADPKLSLM
PWFHGKISGQEAVQQLQPPEDGLFLVRESARHPGDYVLCVSFGRDVIHYRVLHRDGHLTI
DEAVFFCNLMDMVEHYSKDKGAICTKLVRPKRKHGTKSAEEELARAGWLLNLQHLTLGAQ
IGEGEFGAVLQGEYLGQKVAVKNIKCDVTAQAFLDETAVMTKMQHENLVRLLGVILHQGL
YIVMEHVSKGNLVNFLRTRGRALVNTAQLLQFSLHVAEGMEYLESKKLVHRDLAARNILV
SEDLVAKVSDFGLAKAERKGLDSSRLPVKWTAPEALKHGKFTSKSDVWSFGVLLWEVFSY
GRAPYPKMSLKEVSEAVEKGYRMEPPEGCPGPVHVLMSSCWEAEPARRPPFRKLAEKLAR
ELRSAGAPASVSGQDADGSTSPRSQEP
Function
Could play a significant role in the signal transduction of hematopoietic cells. May regulate tyrosine kinase activity of SRC-family members in brain by specifically phosphorylating their C-terminal regulatory tyrosine residue which acts as a negative regulatory site. It may play an inhibitory role in the control of T-cell proliferation.
Tissue Specificity Expressed in various myeloid cell lines, detected in brain and lung.
KEGG Pathway
Neurotrophin sig.ling pathway (hsa04722 )
Reactome Pathway
Downregulation of ERBB2 signaling (R-HSA-8863795 )

Molecular Interaction Atlas (MIA) of This DOT

25 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Neuroblastoma DISVZBI4 Definitive Altered Expression [1]
Acute monocytic leukemia DIS28NEL Strong Biomarker [2]
Acute myelogenous leukaemia DISCSPTN Strong Biomarker [2]
Adenovirus infection DISUYSBZ Strong Altered Expression [3]
Adult glioblastoma DISVP4LU Strong Altered Expression [3]
Astrocytoma DISL3V18 Strong Altered Expression [3]
Brain neoplasm DISY3EKS Strong Altered Expression [3]
Breast cancer DIS7DPX1 Strong Biomarker [4]
Breast carcinoma DIS2UE88 Strong Biomarker [4]
Breast neoplasm DISNGJLM Strong Biomarker [4]
Colonic neoplasm DISSZ04P Strong Biomarker [5]
Dengue DISKH221 Strong Biomarker [6]
Glioblastoma multiforme DISK8246 Strong Altered Expression [3]
Hepatitis C virus infection DISQ0M8R Strong Biomarker [7]
leukaemia DISS7D1V Strong Biomarker [8]
Leukemia DISNAKFL Strong Biomarker [8]
Lung cancer DISCM4YA Strong Genetic Variation [9]
Lung carcinoma DISTR26C Strong Genetic Variation [9]
Multiple sclerosis DISB2WZI Strong Biomarker [10]
Pancreatic cancer DISJC981 Strong Altered Expression [11]
T-cell acute lymphoblastic leukaemia DIS17AI2 Strong Altered Expression [12]
T-cell lymphoma DISSXRTQ Strong Biomarker [13]
Visceral leishmaniasis DISTKEYK Strong Altered Expression [14]
Advanced cancer DISAT1Z9 moderate Biomarker [15]
Hemolytic-uremic syndrome DISSCBGW Limited Genetic Variation [16]
------------------------------------------------------------------------------------
⏷ Show the Full List of 25 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Megakaryocyte-associated tyrosine-protein kinase (MATK). [17]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Megakaryocyte-associated tyrosine-protein kinase (MATK). [25]
------------------------------------------------------------------------------------
9 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Megakaryocyte-associated tyrosine-protein kinase (MATK). [18]
Estradiol DMUNTE3 Approved Estradiol increases the expression of Megakaryocyte-associated tyrosine-protein kinase (MATK). [19]
Arsenic DMTL2Y1 Approved Arsenic affects the expression of Megakaryocyte-associated tyrosine-protein kinase (MATK). [20]
Arsenic trioxide DM61TA4 Approved Arsenic trioxide decreases the expression of Megakaryocyte-associated tyrosine-protein kinase (MATK). [21]
Testosterone DM7HUNW Approved Testosterone increases the expression of Megakaryocyte-associated tyrosine-protein kinase (MATK). [22]
Progesterone DMUY35B Approved Progesterone increases the expression of Megakaryocyte-associated tyrosine-protein kinase (MATK). [23]
SNDX-275 DMH7W9X Phase 3 SNDX-275 increases the expression of Megakaryocyte-associated tyrosine-protein kinase (MATK). [24]
Genistein DM0JETC Phase 2/3 Genistein increases the expression of Megakaryocyte-associated tyrosine-protein kinase (MATK). [19]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Megakaryocyte-associated tyrosine-protein kinase (MATK). [26]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Drug(s)

References

1 Csk homologous kinase inhibits CXCL12-CXCR4 signaling in neuroblastoma.Int J Oncol. 2008 Mar;32(3):619-23.
2 Transcriptional memory of cells of origin overrides -catenin requirement of MLL cancer stem cells.EMBO J. 2017 Nov 2;36(21):3139-3155. doi: 10.15252/embj.201797994. Epub 2017 Oct 4.
3 Differential expression of Csk homologous kinase (CHK) in normal brain and brain tumors.Cancer. 2004 Sep 1;101(5):1018-27. doi: 10.1002/cncr.20442.
4 Csk homologous kinase (CHK) and ErbB-2 interactions are directly coupled with CHK negative growth regulatory function in breast cancer.J Biol Chem. 2002 Sep 27;277(39):36465-70. doi: 10.1074/jbc.M206018200. Epub 2002 Jul 16.
5 Decreased CHK protein levels are associated with Src activation in colon cancer cells.Oncogene. 2008 Mar 27;27(14):2027-34. doi: 10.1038/sj.onc.1210838. Epub 2007 Oct 15.
6 Host plant forensics and olfactory-based detection in Afro-tropical mosquito disease vectors.PLoS Negl Trop Dis. 2018 Feb 20;12(2):e0006185. doi: 10.1371/journal.pntd.0006185. eCollection 2018 Feb.
7 Evaluation of Three Rapid Screening Tests for Detection of Hepatitis C Antibodies on Mass Scale.Crit Rev Eukaryot Gene Expr. 2019;29(1):25-28. doi: 10.1615/CritRevEukaryotGeneExpr.2018025062.
8 Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells.Cancer Cell. 2008 May;13(5):432-40. doi: 10.1016/j.ccr.2008.03.005.
9 Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients.Int J Cancer. 1999 May 5;81(3):325-9. doi: 10.1002/(sici)1097-0215(19990505)81:3<325::aid-ijc2>3.0.co;2-s.
10 Beneficial Effects of the Calcium Channel Blocker CTK 01512-2 in a Mouse Model of Multiple Sclerosis.Mol Neurobiol. 2018 Dec;55(12):9307-9327. doi: 10.1007/s12035-018-1049-1. Epub 2018 Apr 17.
11 CHK negatively regulates Lyn kinase and suppresses pancreatic cancer cell invasion.Int J Oncol. 2006 Dec;29(6):1453-8.
12 Enhancement of Quercetin-Induced Apoptosis by Cotreatment with Autophagy Inhibitor Is Associated with Augmentation of BAK-Dependent Mitochondrial Pathway in Jurkat T Cells.Oxid Med Cell Longev. 2019 Nov 15;2019:7989276. doi: 10.1155/2019/7989276. eCollection 2019.
13 Occult recurrence of monomorphic epitheliotropic intestinal T-cell lymphoma and the role of MATK gene expression in diagnosis.Hematol Oncol. 2017 Dec;35(4):852-855. doi: 10.1002/hon.2288. Epub 2016 Mar 7.
14 TNF signalling drives expansion of bone marrow CD4+ T cells responsible for HSC exhaustion in experimental visceral leishmaniasis.PLoS Pathog. 2017 Jul 3;13(7):e1006465. doi: 10.1371/journal.ppat.1006465. eCollection 2017 Jul.
15 CDKN2A/p16 Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition.Cancer Res. 2018 Feb 1;78(3):781-797. doi: 10.1158/0008-5472.CAN-17-2802. Epub 2017 Dec 11.
16 Wild ungulates as disseminators of Shiga toxin-producing Escherichia coli in urban areas.PLoS One. 2013 Dec 11;8(12):e81512. doi: 10.1371/journal.pone.0081512. eCollection 2013.
17 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
18 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
19 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
20 Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environ Health Perspect. 2008 Apr;116(4):524-31. doi: 10.1289/ehp.10861.
21 Global effects of inorganic arsenic on gene expression profile in human macrophages. Mol Immunol. 2009 Feb;46(4):649-56.
22 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
23 Progesterone increases csk homologous kinase in HMC-1560 human mast cells and reduces cell proliferation. J Cell Biochem. 2007 Dec 1;102(5):1271-80. doi: 10.1002/jcb.21357.
24 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
25 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
26 Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.